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The influence of diabetes and lower limb arterial
disease on cutaneous foot perfusion
Dean T. Williams, MD, Patricia Price, PhD, and Keith G. Harding, MD, Cardiff, United Kingdom
Objective: Peripheral arterial occlusive disease and peripheral neuropathy are major risk factors in diabetic foot disease. We
evaluated the relative influences of noncritical lower limb arterial disease and peripheral neuropathy on cutaneous foot
perfusion in diabetes.
Method: Toe-brachial pressure indices, transcutaneous oxygen, and carbon dioxide tensions at foot and chest sites were
measured in individuals with diabetes, with or without detectable peripheral neuropathy and with or without significant
arterial disease on color duplex imaging. Subjects without diabetes, with and without arterial disease, were used as
controls.
Results: A total of 130 limbs were studied during an 8-month period. Toe-brachial pressure indices reflected the presence
of arterial disease in all groups. Foot transcutaneous oxygen values were reduced in diabetes and correlated with chest
transcutaneous oxygen values. Low foot transcutaneous oxygen with elevated transcutaneous carbon dioxide values were
only demonstrated in individuals with diabetes, arterial disease, and peripheral neuropathy. Toe-brachial pressure indices
demonstrated a positive correlation with foot transcutaneous oxygen values, but values >1.2 demonstrated a negative
correlation.
Conclusions: We demonstrated two influences on cutaneous foot perfusion in diabetes: (1) a global microcirculatory
dysfunction, reflected in low chest and foot transcutaneous oxygen values, and (2) macrovascular disease as indicated by
reduced toe-brachial pressure indices and foot transcutaneous oxygen values. Further, the results demonstrated that in
diabetic individuals without critical limb ischemia, impaired foot perfusion secondary to arterial disease is amplified
significantly by coexisting microcirculatory disease. ( J Vasc Surg 2006;44:770-5.)Patients with diabetes are prone to foot ulceration and
frequently fail to respond to treatments despite optimiza-
tion of the healing environment. Microvascular dysfunc-
tion has been identified in diabetes, but its influence on
cutaneous perfusion in the presence of clinically detectable
peripheral neuropathy and peripheral arterial occlusive dis-
ease (PAOD) is unclear.1 We evaluated changes in foot
perfusion associated with diabetes, detectable peripheral
neuropathy, and PAOD. The presence or absence of
PAOD was established by color duplex imaging, not by
clinical assessment. Most individuals with PAOD had clau-
dication, but several had limited mobility owing to other
factors.
No toe pressures were 30 mm Hg. Foot perfusion
was analyzed in individuals with and without diabetes using
toe-brachial pressure indices (TBI), transcutaneous oxygen
tension (TcPO2) and transcutaneous carbon dioxide
(TcPCO2). TBI is a method widely used for detecting
lower limb PAOD, particularly in individuals with diabetes,
whilst TcPO2 and TcPCO2 are established as indicators of
local cutaneous perfusion.2,3 Individuals with symptoms or
signs of critical ischemia or active foot disease were ex-
cluded to facilitate analysis of the relative influences of
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770microvascular and macrovascular disease on cutaneous per-
fusion.
Exposure of the tests to a representative population
required that subjects with both diabetes types 1 and 2 and
subjects without diabetes be recruited from outpatient
clinics and the community. The study was given ethical
approval by the local ethics committee, and all individuals
included in this study gave informed written consent. Fi-
nancial support for this project was provided by departmen-
tal funds.
PATIENTS AND METHODS
No individuals had active foot disease, rest pain, or
signs suggestive of lower limb critical ischemia. Individuals
without diabetes and with and without peripheral vascular
disease were the controls. Based on pragmatic factors re-
lated to feasibility of recruitment, study duration, and
participant burden, we estimated that an analysis of 120
limbs would be required to facilitate valid comparisons of
the effects of diabetes and PAOD on foot perfusion. Sub-
jects with diabetes were selected consecutively, and control
subjects were selected to match for age and body mass
index (BMI).
Patients with diabetes mellitus were confirmed as hav-
ing diabetes from their medical records. Patients with types
1 and 2 diabetes were included. Subjects were stratified
according to the presence or absence of diabetes, peripheral
vascular disease on color duplex imaging, and peripheral
neuropathy. The nondiabetic control limbs were divided
into those with (V) and without (C) arterial disease. The
diabetes groups were divided into groups based on the
presence (DN) or absence (D) of peripheral neuropathy.
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presence of arterial disease (DNV, DV).
Neuropathy was tested with a 10-gram monofilament,
vibration using a 128-Hz tuning fork, and proprioception
at the first metatarsophalangeal joint, according to the
International Consensus on the Diabetic Foot guidelines.
Loss of sensation of any modality was indicative of periph-
eral neuropathy.
The study was performed during a period of 8 months.
All tests were performed at one visit. All subjects had
arterial color duplex imaging performed at the end of each
attendance. Capillary blood sugar measurements were
taken from all individuals at commencement, including
control individuals to exclude diabetes. The duration of
each subject attendance, together with unreliability of ankle
pressure and laser Doppler in our hands precluded their use
as markers of foot perfusion in this study.
Subject exclusion criteria included: age 40 years;
cigarette smokers3 months of the study date to avoid the
vasoactive effects of nicotine and reduce the likelihood of
coughing; those with other causes of peripheral neuropa-
thy, including spinal conditions, history of alcohol depen-
dence, pernicious anemia, and thyroid disease; a history of
reconstructive vascular surgery, other causes of peripheral
vascular disease, including Buerger’s disease, vasculitis;
those currently involved in vascular interventions; the pres-
ence of pyrexia or foot infection; and significant cardiore-
spiratory or renal disease determined by medication, blood
tests, and clinical assessment.
All hemoglobin values were no lower than 11g/dL.
Levels of serum creatinine in all patients were 0.2
mmol/L, with two exceptions whose levels were about 0.3
mmol/L.
On the morning of the study, all antihypertensive and
oral hypoglycemic medication was omitted, and the insulin
administered was reduced by 50% to reduce the potential
vasoactive effects of these agents. The laboratory room
temperature was maintained between 24°C and 25°C. In-
dividuals were rested reclining at approximately 20° to the
horizontal and acclimatized for a minimum of 20 minutes
before commencing the study. Foot skin temperatures were
measured until a steady state was achieved.
Toe pressures were measured with the photoplethys-
mographic (PPG) method, by using an infrared sensor
placed on the hallux, (Dopplex assist, Huntleigh Health-
care, Cardiff, UK). Toe pressures were taken at 5-minute
intervals on three occasions and a mean calculated.
The TcPO2 and TcPCO2 levels were measured using a
MicroGas 7650 rapid (Kontron Instruments, Milton Key-
nes, UK). The sensor used for measuring PCO2 and PCO2
was a Combi·M Sensor 82 (Linde Medical Sensors AG,
Basel, Switzerland) containing a pH/Clarke silver elec-
trode housed with a heating element, with the temperature
set at 44°C.
Three machines were used, each with a single sensor,
allowing three simultaneous measurements. Each foot elec-
trode was placed on the dorsum between the first and
secondmetatarsal heads, just proximal to the web space andnot over a visible vein. A third reference probe was placed
on the anterior chest wall (midclavicular line, infraclavicular
fossa). Measurement was taken after 15 minutes. Quality
checks were performed every 3 months to ensure intramea-
surement and intermeasurement agreement between the
three probes.
Color duplex imaging was performed at the end of each
visit using a Toshiba SSH-140A (ToshibaMedical Systems,
Crawley, UK) with two probes, a 5-MHz linear array probe
(PLF-503NT) and 3.75-MHz curvilinear probe (PVF-
375MT). All individuals were scanned from the common
femoral artery to the distal third of the tibial and peroneal
arteries. The criteria used for identifying significant arterial
disease in the femoropopliteal segments are listed in Table
I. Occlusions of any of the three arteries below the knee
were also regarded as significant.
Heavy calcification frequently prevented flow analysis
over large segments of the lower limb arteries. However,
distal Doppler analysis was possible in all limbs. Where
heavy calcification prevented flow analysis of segments of
below knee vessels, a damped waveform distally was
deemed to signify occlusive disease was present and main-
tenance of waveform profile its absence. Quality control
was assured by acquiring a second color duplex imaging on
10 individuals with and without arterial disease 1 month
of the original scan. The repeat scan was performed by
medical physicists at the local teaching hospital who were
blinded to the authors’ color duplex imaging findings.
Statistical analysis. Analysis was performed using
SPSS 11 software (SPSS Inc, Chicago, Ill). Group variables
were compared using one-way analysis of variance
(ANOVA) with post hoc multiple comparisons assuming
homogenous variance. Significance was set at P  .05.
Comparisons between transcutaneous measurements and
TBI employed Pearson correlation coefficients with two-
tailed significance set at P  .05.
RESULTS
Demographics. A total of 130 limbs were studied on
68 volunteer subjects (Table II). All subjects were white,
and predominantly male (74%) in the diabetes groups. The
groups were matched for age and BMI (Table II). Gener-
ally there were more type 2 diabetes patients (85% of total)
evenly distributed, except in group five (arterial disease, no
neuropathy), the group with the lowest number of recruits,
Table I. Criteria used for identification of significant
lower limb arterial disease using color duplex imaging
Arterial ultrasound
finding
Change in
peak flow
velocity
Distal waveform
analysis
Occlusion No flow Loss of reverse flow
Single or multiple stenoses 2 increase Loss of reverse flow
Diffuse stenotic disease 2 increase Loss of reverse flowwhich had only type 2 diabetes patients.
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control scans demonstrated complete agreement on the
presence or absence of significant arterial disease. There was
close agreement on the severity of disease detected, four
limbs in complete agreement, and two with 50% stenoses
identified by the author and 50% to 70% by a second color
duplex imaging. The character of arterial disease identified
in each group is summarized in Table III. More occlusions
were identified in the control group, but stenoses and
single distal vessel disease were evenly distributed. Diffuse
femoropopliteal disease was only identified in individuals
with diabetes. Severe arterial calcification, affecting color
duplex imaging in 50% of the arteries visualized, was
encountered in 76% of subjects with diabetes vs 17% in
control groups (Mann-WhitneyU test, two-tail, P .001).
Toe-brachial pressure index. There was close agree-
ment between significant arterial disease detected on color
duplex imaging, toe pressures, and TBI values. All groups
with identified arterial disease had lower values compared
with the remaining groups with no arterial disease (Fig 1).
Statistical analysis, excluding abnormally high TBI values
influenced by digital artery calcification (1.2), identified
the control vascular and diabetic neurovascular groups to
have low mean values (F5, 11514.361, P  .001) (Table
IV). However, using TBI values 0.75 as indicating signif-
Table II. Group distribution and characteristics
Group
no. Abbreviation
Limbs
(n) Age* BMI†
1 V 14 68.89  8.82 26.68  5.39
2 D 25 64.40  8.78 28.59  3.48
3 DN 41 64.75  9.49 30.28  5.38
4 C 27 63.13  12.66 26.07  3.58
5 DV 7 66.17  8.28 29.58  4.58
6 DNV 16 69.45  10.35 28.18  3.40
Total 130
BMI, Body mass index; V, controls with arterial disease; D, diabetes; DN,
diabetes with neuropathy; C, controls; DV, diabetes with arterial disease;
DNV, diabetes with neuropathy arterial disease.
*Mean  SD; analysis of variance F5,74  0.783 P  .565
†Mean  SD; analysis of variance F5,74  2.04 P  .083
Table III. Classification of arterial disease identified in
the three vascular groups
Arterial
disease
Groups
DNV DV V
Occlusion 2 2 5*
Stenosis 6 2 7
Diffuse disease 7 1 0
Distal vessel
occlusion only
1 2 2
Total 16 7 14
DNV, Diabetes with neuropathy; DV, diabetes without neuropathy; V
controls.
*Includes one limb with femoral and distal vessel occlusionicant PAOD (based on control group values), several lowvalues (0.75) were also identified in groups with no
significant arterial disease on color duplex imaging, These
were almost exclusively found in groups with diabetes and
particularly in those with peripheral neuropathy, which in
addition, was the only group identified as having TBI values
1.2. Further analysis of TBI values in the diabetes groups
with no arterial disease demonstrated that a greater degree
of arterial calcification was associated with lower mean
values compared with those limbs with lesser degrees of
calcification on color duplex imaging, 0.81 vs. 0.94, respec-
tively (t  1.997, P  .050).
Transcutaneous oxygen tension. There were only
modest reductions in the mean TcPO2 values of the diabetes
groups with no arterial disease and the control group with
arterial disease compared with the control group (Table V and
Fig 2). However, the group with diabetes, arterial disease, and
peripheral neuropathy demonstrated a mean value that was
lower than the control, control vascular, and diabetes with
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Fig 1. Toe brachial pressure indices (TBI) in all groups.Horizon-
tal line represents TBI value of 0.75. Whiskers represent 95%
confidence intervals (CI). ANOVA F5,11514.63, P  .001
**Significance at P 0.01. Analysis excluding TBI values1.2 in
non-vascular groups.
Table IV. Toe-brachial pressure index (TBI)
Group Mean P
Control vascular 0.47 .001*
Diabetes no neuropathy 0.82 .965
Diabetes neuropathy 0.85 1.0
Control 0.84 1.0
Diabetes vascular 0.58 .061
Diabetes neurovascular 0.48 .001*
Analysis of variance, F5, 11514.63, P  .001
Analysis excluding TBI values  1.2 in nonvascular groups
*Significance P  0.01.neuropathy groups (Table V).4 The reference chest TcPO2
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paredwith the control group (ANOVAF5,121 12.132, P
.001) (Fig 3). There were no differences between the values in
the diabetes groups; however, mean chest TcPO2 values gen-
erally reflected changes in foot TcPO2 values across all groups
(r  0.346, P  .001) (Fig 3).
Transcutaneous carbon dioxide tension. Mean foot
TcPCO2 measurements were higher in the diabetes group
with peripheral neuropathy and arterial disease vs all other
groups except the group with diabetes alone (ANOVA
F5,120  6.358, P  .001). For all limbs, high foot
TcPCO2 values correlated with low TcPO2 (r0.317, P
 .001) (Fig 4). Chest values mirrored foot values with a
close correlation between the two sites (r  0.619, P 
.001).
Toe-brachial pressure index and transcutaneous ox-
ygen tension. Despite TBI values reflecting the presence
Table V. Foot transcutaneous oxygen values
Group
Mean
(mm Hg) P
Control vascular 59.60 0.982
Diabetes no neuropathy 57.24 0.642
Diabetes neuropathy 57.15 0.511
Control 62.58 1
Diabetes vascular 57.00 0.924
Diabetes neurovascular 46.41 0.001*
Analysis of variance, F5,1204.972, P  .001
*Significance P  0.01
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Fig 2. Foot transcutaneous oxygen tension (TcPO2) for all
groups. Horizontal line represents approximate normal value of 60
mm Hg. Whiskers represent 95% confidence intervals (CI).
ANOVA F5,1204.972, P  .001 **Significance at P  0.01
level.of arterial disease identified on color duplex imaging, therewere a wide range of TBI values demonstrated in the
diabetes groups, particularly in those with demonstrable
peripheral neuropathy and no significant arterial disease.
To further analyze this, foot TcPO2 values were correlated
with TBI results for all groups with diabetes.
The correlations performed demonstrated an interest-
ing relationship between the two parameters. In the groups
with arterial disease, increases in foot TcPO2 values corre-
lated closely with increasing TBI (r  0.642, P  .002)
(Fig 5, A). In the diabetes groups with no arterial disease on
color duplex imaging, low TBI values were associated with
low TcPO2 values. However, there was also a strong asso-
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Fig 3. Foot (black, solid line) and chest (gray, dashed line) trans-
cutaneous oxygen tension (TcPO2) for all groups. Whiskers repre-
sent 95% confidence intervals (CI).
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Fig 4. Foot transcutaneous oxygen tension (TcPO2) vs carbon
dioxide tension (TcPCO2) in all diabetes groups. Pearson correla-
tion r  0.317, P  .001.ciation between abnormally high TBI values and low
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TBI and foot TcPO2 (r  0.270, P  .034) (Fig 5, B).
The relationship between the two modalities is graphically
demonstrated when all data for the diabetes groups is
combined (Fig 5, C).
DISCUSSION
The pathophysiology of diabetic foot disease is inti-
mately related to tissue perfusion. Lower limb PAOD can
have profound effects on foot perfusion. Microvascular
disease in diabetes influences the cutaneous response to
injury, but its influence on perfusion in the presence of
detectable peripheral neuropathy and PAOD is unclear.
This study endeavored to determine the influence of these
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Fig 5. Foot transcutaneous oxygen tension (TcPO2) vs toe-bra-
chial pressure index (TBI) for the diabetes groups.A, Subjects with
arterial disease on color duplex imaging. B, Patients with no
arterial disease on color duplex imaging. C, Subjects (A, B)
combined.two variables on cutaneous foot perfusion in diabetes.The selection of subjects with no active foot disease
avoided the potentially confounding influences of sepsis
and ulceration on test interpretation. Group sizes were not
uniform. Recruitment of nonsmokers with arterial disease
but no active foot disease was difficult. The small number of
subjects in the group with diabetes, arterial disease but no
detectable peripheral neuropathy, was a consequence of the
strong association between peripheral neuropathy and
PAOD. Invasive arterial assessment could not be justified in
this study population; however, the accurate detection of
PAOD was critical to the validity of results.
Color duplex imaging. Color duplex imaging was
used as our gold standard in detecting and excluding
PAOD, as the symptoms and signs of noncritical lower limb
PAOD are unreliable, particularly in diabetes.5,6 Color
duplex imaging has been demonstrated to accurately detect
PAOD and is the gold standard in noninvasive testing for
macrovascular disease.7,8
As expected in individuals without critical ischemia,
most of the limbs with PAOD had disease of one segment
only, and individuals with diabetes had more diffuse disease
(Table III). Diffuse stenotic disease was a pattern of ath-
erosclerosis identified only in subjects with diabetes. Vary-
ing degrees of arterial collateralization may, of course,
influence distal perfusion despite similar degrees of main
vessel disease.
It was not surprising that many limbs with PAOD had
normal TcPO2 and TBI values, as none had critical isch-
emia. In agreement with other research, TBI values in this
study generally reflected the presence of significant arterial
disease in all groups with and without diabetes.9 TBI also
correlated closely with foot TcPO2 values. A wide range of
TBI values was demonstrated in the groups with no PAOD
on color duplex imaging, particularly in those groups with
diabetes and peripheral neuropathy. High TBI values, par-
ticularly those1.2, likely reflected the presence of heavily
calcified digital arteries.
The finding of low TBI values in the absence of color
duplex imaging-detected arterial disease, particularly in
those limbs with demonstrable peripheral neuropathy, was
probably partly due to more diffuse arterial disease hidden
by tibioperoneal calcification or disease distal to the area
scanned, or both, a limitation of color duplex imaging in
this study.10 A low TBI appears therefore to be a better
indicator of PAOD than color duplex imaging in this study.
A surprising finding was that TBI values 1.2 were associ-
ated with low TcPO2. Severe digital arterial calcification
may therefore be associated with occult arterial occlusive
disease or a more dysfunctional cutaneous circulation.
Our study, in common with other work, demonstrated
that individuals with diabetes had mild falls in TcPO2
(Table V).11 The group with diabetes and arterial disease
but no peripheral neuropathy demonstrated only mild falls
in TcPO2 and no change in foot TcPCO2, although mean
TBI values were higher than the other vascular groups.
However, abnormally low foot TcPO2 values were demon-
strated in the group with diabetes, arterial disease, and
detectable peripheral neuropathy. In comparison, the con-
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TcPO2 and no change in TcPCO2, despite similar TBI
values. This suggests that despite similar degrees of arterial
disease, individuals with diabetes demonstrate greater re-
ductions in cutaneous foot perfusion, particularly in the
presence of detectable peripheral neuropathy.
The lower chest TcPO2 values in the groups with
diabetes, in agreement with other work, suggests that there
was a global reduction in TcPO2 values.
12 However, our
results demonstrated that these effects were independent of
detectable peripheral neuropathy. Foot TcPCO2 values
were highest in the group with diabetes, peripheral neurop-
athy, and arterial disease, and again correlated closely with
chest measurements. Elevations in TcPCO2 values showed
a negative correlation with TcPO2 across all groups, prob-
ably reflecting altered tissue perfusion, with increasing tis-
sue perfusion facilitating increased oxygen delivery and
more rapid removal of carbon dioxide.
TcPO2 and TcPCO2 results demonstrated that the
group of subjects with diabetes, detectable peripheral neu-
ropathy, and significant arterial disease was the only group
with a reduced cutaneous perfusion. Accepting that the
group with arterial disease and no detectable peripheral
neuropathy was small and interpretation of these results
guarded, the presence of detectable peripheral neuropathy
in diabetes appears to be associated with the greatest dis-
ruption of cutaneous perfusion.
CONCLUSIONS
We can deduce from this study that there were two
influences on cutaneous foot perfusion in subjects with
diabetes and arterial disease: (1) a global microcirculatory
change, as reflected by the close correlation between chest
and foot TcPO2 values, and (2) macrovascular disease
affecting limb perfusion, as limbs identified as having
PAOD had reduced TBI values that correlated with de-
creased TcPO2 values. The minimal effects of noncritical
arterial disease on the cutaneous perfusion of nondiabetic
individuals appears to be exaggerated in diabetes by the
presence of microcirculatory dysfunction to significantly
reduce cutaneous perfusion.
The data suggest that diabetic individuals who have
degrees of noncritical PAOD similar to nondiabetic indi-
viduals are potentially more vulnerable to the detrimental
effects of tissue edema and sepsis on tissue perfusion. These
individuals may therefore not only be more susceptible to
injury but may also be predisposed to delayed healing after
injuries have occurred. This further emphasizes the impor-
tance of an accurate assessment and optimization of perfu-
sion in diabetic foot disease.
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